FDA Advisory Committee Recommends Approval of Novo Nordisk’s Insulin Degludec for Diabetes November 21, 2012 Filed under: Trends-in-Medicine
TRANSCATHETER CARDIOVASCULAR THERAPEUTICS (TCT): RENAL DENERVATION November 9, 2012 Filed under: Trends-in-Medicine
FDA Advisory Committee Recommends Approval of Sanofi’s Kynamro for HoFH October 31, 2012 Filed under: Trends-in-Medicine
FDA Advisory Committee Recommends Approval of Aegerion’s Lomitapide for HoFH October 31, 2012 Filed under: Trends-in-Medicine